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Background.  This letter is a response to a Divergent Views article entitled “The poor 8 
performance of TMM on microRNA-Seq” (Garmire and Subramaniam 2013), which was a 9 
response to our Divergent Views article entitled “miRNA-seq normalization comparisons need 10 
improvement” (Zhou et al. 2013).  Using reproducible code examples, we showed that they 11 
incorrectly used our normalization method and highlighted additional concerns with their study.  12 
Here, I wish to debunk several untrue or misleading statements made by the authors (hereafter 13 
referred to as GS) in their response.  Unlike GS’s, my claims are supported by R code, citations 14 
and email correspondences.  I finish by making a call for better practice. 15 
We will agree to disagree on some aspects, while some claims are just untrue.  Scientists 16 
often disagree and this is important for the furthering of science.  I will reiterate a couple of 17 
important arguments from my perspective, since my interpretation of their original results 18 
contrasts to theirs.  They explain that their original paper focused on “evaluation with different 19 
metrics but not downstream analysis”.  To me, these two go hand-in-hand.  Is it even useful to 20 
have a metric for a “method” that cannot be used downstream?  In particular, the issue of zero 21 
counts should not be disregarded and it is not clear how they intend for quantile and lowess 22 
normalization to be used in the presence of zero counts.  Their claim that “MA plots, and miRNA-23 
qPCR comparisons cannot be done with zero counts” is false; special treatment is given to zero 24 
counts for MA plots, as described in the edgeR and DESeq R/Bioconductor packages (Anders 25 
and Huber 2010; Robinson et al. 2010), among others, and statistical models for count data 26 
readily accommodate zero observations.  Why can these comparisons not be done?  In addition, 27 
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many of the metrics are performed on M-values (log-ratios).  It is well known that the log 1 
transformation introduces higher variance at the low expression strength for count data (Robinson 2 
and Oshlack 2010; Law et al. 2013).  The statistics of differential expression take this into account, 3 
but raw M-value comparisons do not, so in fact M-value metrics may inadvertently overemphasize 4 
low expression values.  Regarding our ROC analyses, GS mention that we “seem to have much 5 
smaller numbers” and suggested this may “obscure the AUC interpretation”.  This may be true; 6 
our analyses are based on the 73 miRNAs that have both count-based M-values and qPCR 7 
ΔΔCts and the R code is available.  I welcome an explanation from GS that explains why their 8 
analyses is to be trusted and ours is not, since they have not responded to our requests for more 9 
information and have not made code available; at the very least, our analyses highlight how 10 
sensitive their analyses to the choics made.  Lastly, GS claim that we have “subsequently revised” 11 
our TMM method.  This is also not true; the method, in terms of calculating normalization factors 12 
over and above the depth of sequencing, has not changed.  We have introduced a convenience 13 
function in the software to give easier access to depth-and-normalization-factor-adjusted counts 14 
and we have changed the internal representation of the normalization factors.  However, we 15 
showed in our Divergent Views Supplement that their normalization factors are off by exactly the 16 
amount of the relative scaling factor, so this change did not affect their original calculations.  The 17 
change in implementation does affect their latest calculations, but I already explained this 18 
modification to them in our email exchanges (Supplementary Note 1).  So, why do GS publish 19 
results that they know are incorrect?  20 
Two striking ironies and further untruths. There are two gleaming ironic comments made in 21 
the GS response. First, regarding performance comparisons with samples from different 22 
experimental conditions instead of biological replicates, they state “we assume that the majority of 23 
the data in experimental conditions are not drastically different when there are no biological 24 
replicates, which is reasonable from the MA plots.”  Yet, in their original manuscript, they rely on 25 
the fact that there are significant differences to make ROC comparisons, in combination with 26 
qPCR validation data.  So, the differences in expression are small enough to be ignored 27 
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comparing performance on M-values, but large enough to used for ROC assessments. I find this 1 
a shaky argument.   Second, in their response, GS point to code from an edgeR user manual.  2 
The overwhelming irony here is that, had they followed this example, they would end up with 3 
correct TMM-adjusted M-values (See additional R code at Supplementary Note 2).   However, 4 
they did not follow this code.  They also did not follow the advice I gave in my original email 5 
correspondence (See Supplementary Note 3). Admittedly, I did not directly show how the 6 
adjustment is done; I hoped it was evident from the code.  GS state that “We therefore used the 7 
normalization factors as described by Robinson and colleagues”, but this is incorrect. What “then-8 
available information” have GS followed?  Amazingly, they have not followed the now-available 9 
information (e.g. Supplementary Note 1) either. 10 
My real disappointment and an alternative interpretation.  Maybe I am just naïve, but science 11 
to me is about the search for truth and ideally a truth that can be reproduced, supported by 12 
defensible arguments and that stands the test of time. Unfortunately, GS seem more interested in 13 
resolving themselves of any software misuse than presenting a honest representation of the 14 
available methods’ performance.  The senior author commented to me in an email: “It is clearly 15 
my intent as is Dr. Garmire’s to correct any errors if they were caused”.  Despite this sentiment, 16 
GS do not appear to be interested that their results have errors and are different to mine.  17 
Specifically, Figures 1 and 2 of their Divergent Views were sent to me in September 2012 and I 18 
responded shortly after (including the RNA editor) to explain that their code did not follow our 19 
example online and that they misinterpreted our original instructions: dividing the count data and 20 
dividing the library sizes by normalization factors are opposite operations (Supplementary Note 21 
1).  Of course, I fully recognize my own irony here.  Despite the efforts to correct the miRNA-seq 22 
normalization, TMM is only marginally better than total-count normalization (See Figure 1).  23 
However, given that some methods have never been used for sequencing data and do not have a 24 
clear path to downstream analysis, an alternative conclusion is that TMM is perhaps among the 25 
best methods available.  26 
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A couple of recommendations. I have a couple of recommendations for making these 1 
interactions smoother in the future.  First, vague questions do not (often) attract good answers, so 2 
I encourage people to ask questions in a clear and engaging way.  For example, provide a 3 
snippet of code, give a plot that shows an unusual result, give ancillary information such as 4 
software version and overall, make it easy for the responder to know what you are trying to 5 
achieve (without giving sensitive information away).  The reason I did not respond directly to their 6 
original query, is that the business of where to put the normalization factors gets admittedly 7 
confusing.  I had hoped that pointing to a reproducible example would be a good strategy, but in 8 
hindsight, this exposes us to misinterpretation.  I am not discouraged by this experience though; I 9 
will continue to make code available.  Second, software and recommendations may change over 10 
time and it is important to follow the instructions that go with the version of software being used.  11 
This requires special care, since the web is awash with old user guides and code that no longer 12 
runs correctly.  Third and most importantly, data analysts should make code available for all 13 
analyses and comparisons, potentially including code to recreate every figure (and table) of every 14 
paper.  This is by no means a new concept (Morin et al. 2012; Ince et al. 2012) and journals are 15 
beginning to take additional editorial measures (Editorial 2013).  The tools available to do this, 16 
especially for R, are readily available (e.g. Sweave, github).  That way, data analysis is not a 17 
black box. 18 
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Figure 1. A) Original incorrect GS analysis.  B) Updated incorrect GS analysis. C) Our corrected re-
analysis. 
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